← Evidence map

ArticleEMBO molecular medicine2026

Selective mRNA translation determines adaptative mutability of melanoma cells to anti-BRAF/MEK combination therapy.

Lucilla Fabbri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42477455